Biostar Pharmaceuticals reports income of $15.

Biostar Pharmaceuticals reports income of $15.01M for third quarter 2013 Biostar Pharmaceuticals, Inc nizagara100.com . , a PRC based producer and internet marketer of pharmaceutical and product items in China for a number of diseases and conditions, today announced its financial outcomes of the 3rd quarter ended September 30, 2013. Overview FINANCIALS Third Quarter 2013 Financial Results Income for the 3rd One fourth of 2013 was $15.01M, representing a considerable increase more than the same amount of the last year. Cost of Product sales for the 3rd One fourth of 2013 elevated over the same one fourth of 2012 by $3.33M or 70.6 percent because of a rise in net product sales and the introduction of the brand new hospital items.

http://www.nizagara100.com

The brand new polymer offers improved functionality and processing features for medical devices. This breakthrough technology allows medical products to be built with permanent surface area modification while maintaining exceptional mechanical properties. Additionally, it may eliminate the dependence on secondary surface remedies once a gadget is manufactured.